-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ketamine is often used in the treatment of refractory chronic pain.
A total of 20 patients with neuropathic pain were included in the study.
The results showed that within 35 days, there was no significant difference in daily pain intensity between the three groups (n = 20) (the average area under the curve of ketamine, ketamine/magnesium and placebo were 185±100, 196±92, and 187±, respectively 90 pain score-days, P=0.
In summary, the results of the study showed that ketamine was not superior to placebo in providing pain relief within 5 weeks, and the combination with magnesium did not produce any additional benefits.
Original source:
Gisèle Pickering, et al.
ncbi.
nlm.
nih.
gov/32384291/" target="_blank" rel="noopener">Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial in this message